Try GOLD - Free

Banks' good run on, but there are challenges

Business Standard

|

November 24, 2025

Net profits grew, but operating profits were down for many banks in the Sep quarter. What does it say?

- TAMAL BANDYOPADHYAY

One more reasonably good earnings quarter for Indian banks, with the quality of loan assets remaining pristine.

Net profit of every bank may not be handsome-some have even posted a drop in net profits - but for the first time, the collective net profits of listed private and publicsector banks (PSBs) crossed the 1.5 trillion mark in the September quarter of 2025-26. At 1.51 trillion, it was up 4.4 per cent year-on-year (Yo-Y). Quarter-on-quarter (q-o-q)-in the September quarter over the June quarter-the net profits of this set of universal banks was up 3.98 per cent.

Barring two PSBs, the banks that reported a drop in net profits Y-o-Yand even Q-o-Q in some cases-are all from the private sector. The quantum of drop in net profits varies, and so do the reasons behind it from higher provisioning for taking care of pockets of stress to slower growth or drop in income, both interest income and the so-called other income, including fees and treasury profits. IndusInd Bank Ltd was the only entity which posted a loss in this quarter.

State Bank of India (SBI) topped the list with a 20,160 crore net profit, followed by HDFC Bank Ltd (18,641 crore), ICICI Bank Ltd (12,359 crore) and Axis Bank Ltd (₹5,090 crore). These banks formed the ₹5,000 crore-plus net profit earning quartet in the September quarter. Four banks among the PSBS -Punjab National Bank, Bank of Baroda, Canara Bank and Union Bank of India-recorded net profits of over 4,000 crore. And two-one PSB (Indian Bank) and a private bank (Kotak Mahindra Bank Ltd) formed the ₹3,000 crore-plus net profit club.

All figures are rounded off.

While the net profits rose, the operating profits dropped-both Y-oYand Q-o-Q-for the industry.

MORE STORIES FROM Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size